We've found
184,457
clinical trials
Marburg Virus Disease Clinical Trial
A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Dapagliflozin In Alzheimer's Disease
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Predicting the Development of Myocardial Depression in Acute Neurological Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Avelumab-M3814 Combinations
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Trichotillomania Clinical Trial
Telepsychotherapy for the Treatment of Adolescents With Trichotillomania
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prader-Willi Syndrome Clinical Trial
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prader-Willi Syndrome Clinical Trial
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prader-Willi Syndrome Clinical Trial
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prader-Willi Syndrome Clinical Trial
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prader-Willi Syndrome Clinical Trial
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Tourette's Disorder (TD) Clinical Trial
Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Subjects With Tourette's Disorder
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Tourette's Disorder (TD) Clinical Trial
Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Subjects With Tourette's Disorder
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Myelodysplastic Syndromes Clinical Trial
Efficacy and Safety Study of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell Transfusions
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Myelodysplastic Syndromes Clinical Trial
Efficacy and Safety Study of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell Transfusions
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Myelodysplastic Syndromes Clinical Trial
Efficacy and Safety Study of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell Transfusions
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Healthy Clinical Trial
Effects of Glutathione on Immunity in Individuals Training for a Marathon
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
IMMU-132 in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
IMMU-132 in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
IMMU-132 in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Gastroenterology Clinical Trial
Transcutaneous Electroacupuncture for Gastric Complications of Scleroderma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Eosinophilic Esophagitis Clinical Trial
Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lung; Node Clinical Trial
Robotic Bronchoscopy for Peripheral Pulmonary Lesions
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Nicotinamide Riboside in LVAD Recipients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Spinal Cord Injuries Clinical Trial
Exercise Training and Manual Wheelchair Users With SCI
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hearing Loss, Sensorineural Clinical Trial
Expanded Indications in the Adult Cochlear Implant Population
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hearing Loss, Sensorineural Clinical Trial
Expanded Indications in the Adult Cochlear Implant Population
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Spontaneous Urticaria Clinical Trial
A Phase III Study of Efficacy and Safety of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Spontaneous Urticaria Clinical Trial
A Phase III Study of Efficacy and Safety of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Spontaneous Urticaria Clinical Trial
A Phase III Study of Efficacy and Safety of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Evaluation of VX 445/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Visual Outcomes for Toric Efficacy Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Marburg Virus Disease Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Updated: 12/31/1969
Dapagliflozin In Alzheimer's Disease
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Predicting the Development of Myocardial Depression in Acute Neurological Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study of Avelumab-M3814 Combinations
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Trichotillomania Clinical Trial
Updated: 12/31/1969
Telepsychotherapy for the Treatment of Adolescents With Trichotillomania
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prader-Willi Syndrome Clinical Trial
Updated: 12/31/1969
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prader-Willi Syndrome Clinical Trial
Updated: 12/31/1969
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prader-Willi Syndrome Clinical Trial
Updated: 12/31/1969
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prader-Willi Syndrome Clinical Trial
Updated: 12/31/1969
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prader-Willi Syndrome Clinical Trial
Updated: 12/31/1969
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Tourette's Disorder (TD) Clinical Trial
Updated: 12/31/1969
Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Subjects With Tourette's Disorder
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Tourette's Disorder (TD) Clinical Trial
Updated: 12/31/1969
Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Subjects With Tourette's Disorder
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Myelodysplastic Syndromes Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell Transfusions
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Myelodysplastic Syndromes Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell Transfusions
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Myelodysplastic Syndromes Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell Transfusions
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Healthy Clinical Trial
Updated: 12/31/1969
Effects of Glutathione on Immunity in Individuals Training for a Marathon
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
IMMU-132 in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
IMMU-132 in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
IMMU-132 in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
Updated: 12/31/1969
Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Gastroenterology Clinical Trial
Updated: 12/31/1969
Transcutaneous Electroacupuncture for Gastric Complications of Scleroderma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Eosinophilic Esophagitis Clinical Trial
Updated: 12/31/1969
Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lung; Node Clinical Trial
Updated: 12/31/1969
Robotic Bronchoscopy for Peripheral Pulmonary Lesions
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Nicotinamide Riboside in LVAD Recipients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Spinal Cord Injuries Clinical Trial
Updated: 12/31/1969
Exercise Training and Manual Wheelchair Users With SCI
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hearing Loss, Sensorineural Clinical Trial
Updated: 12/31/1969
Expanded Indications in the Adult Cochlear Implant Population
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hearing Loss, Sensorineural Clinical Trial
Updated: 12/31/1969
Expanded Indications in the Adult Cochlear Implant Population
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Spontaneous Urticaria Clinical Trial
Updated: 12/31/1969
A Phase III Study of Efficacy and Safety of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Spontaneous Urticaria Clinical Trial
Updated: 12/31/1969
A Phase III Study of Efficacy and Safety of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Spontaneous Urticaria Clinical Trial
Updated: 12/31/1969
A Phase III Study of Efficacy and Safety of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
Evaluation of VX 445/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
Troriluzole in Adult Subjects With Spinocerebellar Ataxia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Updated: 12/31/1969
Visual Outcomes for Toric Efficacy Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Updated: 12/31/1969
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Updated: 12/31/1969
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Updated: 12/31/1969
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials